IS5244A - Ný aðferð við að framleiða lyfjafræðilega virkar útskiptar-(6,7-díhýdró-4H-þíenó[3,2-C]pýridín-5-ýl)ediksýruafleiður - Google Patents

Ný aðferð við að framleiða lyfjafræðilega virkar útskiptar-(6,7-díhýdró-4H-þíenó[3,2-C]pýridín-5-ýl)ediksýruafleiður

Info

Publication number
IS5244A
IS5244A IS5244A IS5244A IS5244A IS 5244 A IS5244 A IS 5244A IS 5244 A IS5244 A IS 5244A IS 5244 A IS5244 A IS 5244A IS 5244 A IS5244 A IS 5244A
Authority
IS
Iceland
Prior art keywords
thieno
pyridin
dihydro
acetic acid
acid derivatives
Prior art date
Application number
IS5244A
Other languages
English (en)
Other versions
IS1883B (is
Inventor
βria Bakonyi M
Csat βriné Nagy Marianna
Moln βr Leventéné
Gaj βry Antal
Alatty βni Edit
Original Assignee
Sanofi-Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis
Publication of IS5244A publication Critical patent/IS5244A/is
Publication of IS1883B publication Critical patent/IS1883B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
IS5244A 1997-05-13 1999-11-11 Ný aðferð við að framleiða lyfjafræðilega virkar útskiptar-(6,7-díhýdró-4H-þíenó[3,2-C]pýridín-5-ýl)ediksýruafleiður IS1883B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9700885A HU222283B1 (hu) 1997-05-13 1997-05-13 Eljárás tieno[3,2-c]piridin-származékok előállítására
PCT/HU1998/000048 WO1998051689A1 (en) 1997-05-13 1998-05-11 A new process for the preparation of a pharmacologically active substance

Publications (2)

Publication Number Publication Date
IS5244A true IS5244A (is) 1999-11-11
IS1883B IS1883B (is) 2003-08-15

Family

ID=90014236

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5244A IS1883B (is) 1997-05-13 1999-11-11 Ný aðferð við að framleiða lyfjafræðilega virkar útskiptar-(6,7-díhýdró-4H-þíenó[3,2-C]pýridín-5-ýl)ediksýruafleiður

Country Status (38)

Country Link
US (1) US6180793B1 (is)
EP (1) EP0981529B1 (is)
KR (1) KR100428238B1 (is)
CN (1) CN1109036C (is)
AR (1) AR014349A1 (is)
AT (1) ATE212025T1 (is)
AU (1) AU735702B2 (is)
BR (1) BR9809112B1 (is)
CA (1) CA2289623C (is)
CO (1) CO4950564A1 (is)
CZ (1) CZ292820B6 (is)
DE (1) DE69803176T2 (is)
DK (1) DK0981529T3 (is)
DZ (1) DZ2487A1 (is)
EE (1) EE03925B1 (is)
EG (1) EG21973A (is)
ES (1) ES2172141T3 (is)
HK (1) HK1027350A1 (is)
HR (1) HRP980240B1 (is)
HU (1) HU222283B1 (is)
ID (1) ID23018A (is)
IL (1) IL132774A0 (is)
IS (1) IS1883B (is)
ME (1) ME01636B (is)
MY (1) MY121299A (is)
NO (1) NO325419B1 (is)
NZ (1) NZ501577A (is)
PL (1) PL194859B1 (is)
PT (1) PT981529E (is)
RS (1) RS49626B (is)
RU (1) RU2172315C1 (is)
SA (1) SA98190583B1 (is)
SK (1) SK283700B6 (is)
TR (1) TR199902783T2 (is)
TW (1) TW552263B (is)
UA (1) UA66359C2 (is)
WO (1) WO1998051689A1 (is)
ZA (1) ZA983921B (is)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2769313B1 (fr) * 1997-10-06 2000-04-21 Sanofi Sa Derives d'esters hydroxyacetiques, leur procede de preparation et leur utilisation comme intermediaires de synthese
HU226421B1 (en) * 1998-11-09 2008-12-29 Sanofi Aventis Process for racemizing optically active 2-(2-chlorophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides
IN191030B (is) * 2001-01-24 2003-09-13 Cadila Healthcare Ltd
US6495691B1 (en) 2001-07-06 2002-12-17 Brantford Chemicals Inc. Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
ITMI20020933A1 (it) * 2002-05-03 2003-11-03 Danimite Dipharma S P A Procedimento per la sintesi di clopidogrel
US6800759B2 (en) * 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
US6812363B2 (en) * 2002-10-15 2004-11-02 Usv Limited Racemization of optically active 2-substituted phenyl glycine esters
AU2003216707A1 (en) * 2003-03-10 2004-09-30 Hetero Drugs Limited Amorphous clopidogrel hydrogen sulfate
EP1603920A1 (en) 2003-03-12 2005-12-14 Cadila Healthcare Ltd. Polymorph and amorphous form of (s)-(+)-clopidogrel bisulfate
GB0321256D0 (en) * 2003-09-11 2003-10-08 Generics Uk Ltd Novel crystalline compounds
US8907090B2 (en) 2003-11-03 2014-12-09 Cadila Healthcare Limited Processes for preparing different forms of (S)-(+)-Clopidogrel bisulfate
CA2457459A1 (en) * 2004-02-11 2005-08-11 Brantford Chemicals Inc. Resolution of racemates of methyl alpha-5-(4,5,6,7-tetrahydro(3,2-c)thienopyridyl)-(2-chlorophenyl) acetate
KR100553398B1 (ko) * 2004-03-12 2006-02-16 한미약품 주식회사 티에노[3,2-ｃ]피리딘 유도체의 제조 방법 및 이에사용되는 중간체
KR20070052780A (ko) * 2004-09-21 2007-05-22 테바 파마슈티컬 인더스트리즈 리미티드 결정질 클로피도그렐 브롬산염 및 이의 제조 방법
US20060223845A1 (en) * 2005-02-24 2006-10-05 Eran Turgeman Clopidogrel base suitable for pharmaceutical formulation and preparation thereof
KR100681512B1 (ko) 2005-03-08 2007-02-09 주식회사 한서켐 클로피도그렐의 신규한 제조 중간체 및 이를 이용한 클로피도그렐의 제조방법
KR101235117B1 (ko) 2005-12-26 2013-02-20 에스케이케미칼주식회사 광학분리에 의한 (ｓ)-(＋)-클로피도그렐의 제조방법
CA2650471A1 (en) * 2006-04-27 2007-11-08 Ind-Swift Laboratories Limited Process for the preparation of polymorphic forms of clopidogrel hydrogen sulfate
CA2655844A1 (en) * 2006-08-03 2008-02-14 Teva Pharmaceutical Industries Ltd. Process for preparing clopidogrel bisulphate
US8247558B2 (en) 2006-09-04 2012-08-21 Ranbaxy Laboratories Limited Process for the preparation of clopidogrel and its pharmaceutically acceptable salts
EP1980563A1 (en) 2007-04-09 2008-10-15 BATTULA, Srinivasa Reddy Procedure for the preparation of methyl (+)-(S)-Alpha-(O-chlorophenyl)-6,7-dihydrothieno-[3,2-C]pyridine-5(4H) acetate
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
US20090264460A1 (en) * 2008-04-21 2009-10-22 Mamta Mishra Clopidogrel pharmaceutical formulations
KR100990949B1 (ko) 2008-06-09 2010-10-29 엔자이텍 주식회사 클로피도그렐 및 그의 유도체의 제조방법
EP2346879A1 (en) * 2008-10-24 2011-07-27 Sandoz AG A process for the preparation of s-clopidogrel
US8563690B2 (en) * 2008-11-03 2013-10-22 The Board Of Trustees Of The University Of Illinois Modulation of platelet aggregation
CN101544655B (zh) * 2009-05-05 2012-07-04 上海医药集团股份有限公司 噻吩并[3，2-c]吡啶衍生物的制备方法
CN101863899B (zh) * 2010-06-21 2013-03-20 常州制药厂有限公司 一种提高氯吡格雷樟脑磺酸盐拆分收率的方法
KR20170004282A (ko) 2015-07-02 2017-01-11 류종렬 수도 지지부가 구비된 쉐이크 핸드형 탁구 라켓
KR20170004283A (ko) 2015-07-02 2017-01-11 류종렬 그립부가 개선된 쉐이크 핸드형 탁구 라켓

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530247B1 (fr) 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
FR2608607B1 (fr) 1986-12-23 1989-04-28 Sanofi Sa Procede de preparation de thienylethylamines et dithienylethylamines ainsi obtenues
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2652575B1 (fr) * 1989-09-29 1992-01-24 Sanofi Sa Procede de preparation d'acides alpha-bromo phenylacetiques.
FR2664596B1 (fr) 1990-07-10 1994-06-10 Sanofi Sa Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese.

Also Published As

Publication number Publication date
HUP9700885A2 (hu) 1999-09-28
IS1883B (is) 2003-08-15
MY121299A (en) 2006-01-28
PL336693A1 (en) 2000-07-03
RU2172315C1 (ru) 2001-08-20
YU58799A (sh) 2002-06-19
WO1998051689A1 (en) 1998-11-19
BR9809112A (pt) 2000-08-01
SA98190583B1 (ar) 2006-08-19
NO325419B1 (no) 2008-04-21
RS49626B (sr) 2007-08-03
TW552263B (en) 2003-09-11
CN1255924A (zh) 2000-06-07
DE69803176T2 (de) 2002-08-22
ZA983921B (en) 1998-11-09
ME01636B (me) 2007-08-03
HU222283B1 (hu) 2003-05-28
EP0981529B1 (en) 2002-01-16
ATE212025T1 (de) 2002-02-15
AR014349A1 (es) 2001-02-28
HRP980240A2 (en) 1999-02-28
DZ2487A1 (fr) 2004-07-30
DE69803176D1 (de) 2002-02-21
HUP9700885A3 (en) 2000-06-28
CZ292820B6 (cs) 2003-12-17
EG21973A (en) 2002-05-31
ID23018A (id) 1999-12-30
PL194859B1 (pl) 2007-07-31
AU7444898A (en) 1998-12-08
PT981529E (pt) 2002-06-28
CA2289623C (en) 2007-01-30
DK0981529T3 (da) 2002-04-22
HRP980240B1 (en) 2003-02-28
NZ501577A (en) 2001-10-26
US6180793B1 (en) 2001-01-30
JP4256478B2 (ja) 2009-04-22
HUP9700885D0 (en) 1997-07-28
CA2289623A1 (en) 1998-11-19
AU735702B2 (en) 2001-07-12
CN1109036C (zh) 2003-05-21
TR199902783T2 (xx) 2000-04-21
CO4950564A1 (es) 2000-09-01
JP2001525819A (ja) 2001-12-11
SK151699A3 (en) 2000-07-11
EE9900488A (et) 2000-06-15
EE03925B1 (et) 2002-12-16
HK1027350A1 (en) 2001-01-12
KR100428238B1 (ko) 2004-04-30
BR9809112B1 (pt) 2010-10-05
ES2172141T3 (es) 2002-09-16
EP0981529A1 (en) 2000-03-01
IL132774A0 (en) 2001-03-19
UA66359C2 (uk) 2004-05-17
NO995533L (no) 1999-12-13
CZ393999A3 (cs) 2000-04-12
NO995533D0 (no) 1999-11-12
KR20010012511A (ko) 2001-02-15
SK283700B6 (sk) 2003-12-02

Similar Documents

Publication Publication Date Title
IS5244A (is) Ný aðferð við að framleiða lyfjafræðilega virkar útskiptar-(6,7-díhýdró-4H-þíenó[3,2-C]pýridín-5-ýl)ediksýruafleiður
AU1325001A (en) Methods of making a superconductor
AU5167898A (en) A method for the production of levulinic acid and its derivatives
AU7333396A (en) Thienopyridine derivatives as gonadotropin releasing hormone antagonists
HUP0203851A3 (en) Method for production of a triazolinethione derivative
AU9354498A (en) Hydroxyacetic ester derivatives, preparation method and use as synthesis intermediates
AU7125300A (en) Method of image transfer to a colored base
AU7432400A (en) Preparation of benzenediboronic acid via a disilylated aryl-intermediate
HK1047932A1 (zh) 製備2-雜環基甲基苯甲酸衍生物的方法
IL146580A0 (en) Method of producing nitroguanidine-and nitroenamine derivatives
AU1130201A (en) Method of producing a superconducting cable
HUP0101728A3 (en) 5-hydroxybenzo[b]thiophene-3-carboxylic acid and their derivatives and methods for producing them
HUP0202728A3 (en) Process for preparation of phenylacetic acid derivatives
PL328375A1 (en) Method of obtaining a methylester of 2-(2-methylphenyl)-3-methoxyacrylic acid
PL338628A1 (en) Method of obtaining derivatives of 2,3,3a,4,6,7-hexahydropyrasole [4,3-c] pyridine, method of obtaining l-tartrate of such derivative and novel polymorph of dihydrate of so obtained l-tartrate
FI916036A0 (fi) Menetelmä valmistaa farmaseuttisesti käyttökelpoista spirofuraanijohdosta
AU1130301A (en) Method of producing a superconducting cable
AU3554700A (en) Method of diagnosing a golf swing
AU2001228789A1 (en) A one-pot process for the preparation of pharmaceutically acceptable acid addition salts of 4, 5, 6, 7 tetrahydrothieno (3,2-c) pyridine derivatives having antithrombotic activity
PL338742A1 (en) Method of obtaining derivatives of dioxypenicillanic acid
PL332103A1 (en) Method of obtaining therapeutically active derivative of pyrazol pyrimidino
AU8244998A (en) A process of manufacturing camptothecin derivatives
PL340055A1 (en) Novel derivatives of methylene biphosphonic acid
HUP0300392A3 (en) Benzo[a]phenazin-11-carboxamide derivatives, their use for producing pharmaceutical compositions with effect joint inhibitors of topomerase i and ii, process for their preparation and their intermediates
AU5575998A (en) Process for producing benzylsuccinic acid derivatives